ACST-2 TRIAL randomizzato multicentrico in collaborazione con HTA/BUPA Foundation/University of Oxford sulla Chirurgia carotidea versus stenting.
ACST-2 is a large, simple international randomised trial comparing surgery (CEA) versus stenting (CAS) in patients with asymptomatic carotid stenosis where there is substantial uncertainty as to which treatment is more appropriate. ACST-2 seeks to compare these procedures and their benefit in stroke prevention. ACST-2 is currently recruiting patients from all over the world through very experienced collaborators in many different countries. The trial hopes to recruit many thousands of patients over the next few years for a meaningful comparison between surgery and stenting.
Nuffield Department of Surgical Science dell'Univesità di Oxford ha conferito alla Chirurgia Vascolare dell'Istituto Auxologico Italiano IRCCS nell'ambito del Trial ACST-2 i seguenti Awards:
- Centre of the Year 2013
- Overall Top Recruitment Centre 2014 > 2020
- Platinum Award Centre 2016 > 2020
- Recruitment Leader in 2020